Šimčíková, Daniela
Gardáš, Dominik
Pelikán, Tomáš
Moráň, Lukáš
Hruda, Martin
Hložková, Kateřina
Pivetta, Tiziana
Hendrych, Michal
Starková, Júlia
Rob, Lukáš
Vaňhara, Petr
Heneberg, Petr
Funding for this research was provided by:
Univerzita Karlova v Praze (324421, 324421, 324421)
Agentura Pro Zdravotnický Výzkum České Republiky (NU21-03-00539)
Article History
Received: 30 January 2024
Accepted: 5 September 2024
First Online: 16 September 2024
Declarations
:
: The use of primary cells was approved by the Ethics Committee of the Third Faculty of Medicine, Charles University (approval not numbered, dated April 29, 2020) and by the Ethics Committee of the University Hospital Královské Vinohrady (approval #EK-VP/24/0/2020, dated June 3, 2020). Written informed consent was obtained from each donor of primary cells.
: Not applicable.
: DS, DG, and PH were funded by the Charles University in Prague project GA UK 324421. LM was funded by the Czech Health Research Council project NU21-03-00539. LM and PV were funded by the Masaryk University project MUNI/A/1598/2023. KH and JS were funded by the European Union – Next Generation EU – program No. LX22NPO5102. The authors declare no other competing interests.